Exploring the professional issue of group B streptococcus screening in pregnancy
Place of Publication
Faculty of Health, Engineering and Science
School of Medical and Health Sciences
Throughout pregnancy, women are offered various screenings and diagnostic procedures. Group B Streptococcus (GBS) screening is currently a routine screening process in Australia, but not in the United Kingdom, which is offered to women at 35–37 weeks gestation. The results of GBS screening alter a woman's course of care for labor and the postnatal period. This article is a review of evidence, policy, and clinical practice and aims to determine whether GBS screening is necessary and whether the screening has a positive or negative impact on women and their babies.
Not open access